Peer-influenced content. Sources you trust. No registration required. This is HCN.
Ophthalmology Advisor
The approval was supported by data from two phase 3 trials demonstrating improvement in near vision within 30 minutes after administration lasting up to 10 hours.
Family Medicine/General Practice November 10th 2025
Contact Lens Spectrum
Learn how an integrative approach involving specialty lenses and pharmaceuticals can revolutionize treatment strategies for ocular and corneal conditions.
Optometry September 26th 2023
Modern Optometry
New pharmaceutical interventions are significantly broadening the scope of presbyopia treatment. Discover how these emerging options can enhance your practice and improve patient care.